Cannabis and Cortisol: How Weed Affects Stress Hormones

Why Your Stress Hormones Care About Cannabis

Here is a fact that might surprise you: every time you consume cannabis, you are not just altering your mood or perception. You are having a direct conversation with your body’s stress response system. Specifically, cannabinoids interact with cortisol, the hormone most people call “the stress hormone,” in ways that researchers are only beginning to fully understand.

Cortisol gets a bad reputation. Yes, chronically elevated cortisol is linked to anxiety, weight gain, poor sleep, and a list of health concerns. But cortisol is also essential. It wakes you up in the morning, helps you respond to danger, regulates inflammation, and keeps your blood sugar stable. The problem is not cortisol itself — it is when the system gets stuck in overdrive.

So what happens when cannabinoids like THC and CBD enter the picture? Some research suggests cannabis may lower cortisol levels acutely, while other findings point to a more complex, dose-dependent relationship that changes with long-term use. For anyone using cannabis to unwind after a stressful day — or anyone who has ever felt more anxious after consuming — understanding this hormonal interplay is genuinely useful.

In this article, we will break down the science of cortisol, explore what research tells us about how cannabinoids interact with the hypothalamic-pituitary-adrenal (HPA) axis (your body’s central stress command center), examine the role of your endocannabinoid system as the native stress buffer, look at what terpenes may contribute, and connect all of it to practical choices you can make about your cannabis experience.

The HPA Axis: Your Body’s Stress Command Center

Before we can understand how cannabis affects cortisol, we need to understand the system that produces it. Think of the HPA axis as a three-step relay race inside your body:

1. The Hypothalamus (the starter pistol): This small region at the base of your brain detects stress — whether it is a looming deadline, a near-miss in traffic, or even low blood sugar. It releases a signaling molecule called corticotropin-releasing hormone (CRH).

2. The Pituitary Gland (the middle runner): CRH tells the pituitary to release adrenocorticotropic hormone (ACTH) into the bloodstream.

3. The Adrenal Glands (the anchor leg): ACTH reaches the adrenal glands sitting on top of your kidneys, which then pump out cortisol.

Once cortisol levels rise high enough, they signal back to the hypothalamus and pituitary to stop the cascade — a negative feedback loop. Imagine a thermostat: when the room gets warm enough, the heater shuts off. When cortisol is high enough, the brain says “we are good, stop producing more.”

This system works beautifully for acute, short-term stress. The problem arises when chronic stress keeps the thermostat cranked up. Over time, the feedback loop can become less sensitive, leading to persistently elevated cortisol — a state associated with anxiety, disrupted sleep, impaired immune function, and metabolic issues. Research indicates that approximately 60-70% of individuals under chronic stress display abnormal cortisol rhythms [Chrousos, 2009].

Cortisol also follows a circadian rhythm. It peaks in the early morning during what scientists call the cortisol awakening response (CAR) — that surge that helps you get out of bed — and gradually declines throughout the day, reaching its lowest point around midnight. Chronic stress can flatten this curve, lowering the morning peak and elevating nighttime levels, which helps explain why stressed individuals often feel exhausted in the morning and wired at night [Adam et al., 2017].

The Endocannabinoid System: Your Native Stress Buffer

Here is where the story becomes remarkable for cannabis users. Your body does not just have a stress response system — it has a built-in system for regulating that response. The endocannabinoid system (ECS) is deeply intertwined with the HPA axis, acting as one of its primary modulators.

The ECS operates through two main endocannabinoids — anandamide (AEA) and 2-arachidonoylglycerol (2-AG) — and two primary receptors, CB1 and CB2. CB1 receptors are especially dense in the brain regions that govern the stress response: the hypothalamus, the amygdala, the hippocampus, and the prefrontal cortex [Herkenham et al., 1991].

What makes the ECS so relevant to cortisol is the elegant yin-yang relationship between anandamide and 2-AG during stress, as described in a comprehensive review by Morena et al. (2016) in Neuropsychopharmacology:

Anandamide: The Gatekeeper

Under normal, non-stressed conditions, anandamide maintains a tonic signal in the amygdala that keeps the HPA axis quiet. Think of it as a security guard at the door of your stress response — as long as anandamide is on duty, the alarm stays silent.

When a stressor arrives, the brain releases CRH, which activates an enzyme called FAAH (fatty acid amide hydrolase) in the amygdala. FAAH rapidly breaks down anandamide, removing the guard from the door and allowing the stress response to activate. This decline in anandamide appears to contribute directly to the manifestation of the stress response, including HPA axis activation and increases in anxiety behavior [Gray et al., 2015].

2-AG: The Off Switch

While anandamide falls during stress, 2-AG levels rise — but on a delayed timeline. This increase in 2-AG appears to be driven by cortisol itself as part of the negative feedback loop. Glucocorticoids stimulate the production of 2-AG, which then activates CB1 receptors to help terminate the stress response and bring the HPA axis back to baseline [Evanson et al., 2010].

A striking demonstration of this comes from human studies on parabolic flight stress. Individuals who showed an increase in circulating 2-AG during stress exhibited minor changes in HPA axis function, while those who failed to mobilize 2-AG showed massive increases in cortisol [Chouker et al., 2010]. In other words, your ability to mount a 2-AG response may directly determine how much cortisol stress squeezes out of you.

Chronic Stress Degrades the System

Under chronic stress, this elegant system begins to break down. Sustained stress reliably causes a downregulation of CB1 receptors in almost every brain region examined, along with persistent reductions in anandamide signaling [Hill et al., 2010]. The stress buffer weakens. This creates a vicious cycle: chronic stress impairs the very system designed to limit the stress response, which leads to more cortisol, which leads to more impairment.

This is the biological context into which cannabis enters. When you consume THC or CBD, you are introducing external cannabinoids into a system that may already be struggling to regulate cortisol on its own.

THC and Cortisol: A Dose-Dependent Dance

The relationship between THC and cortisol is one of the more well-studied areas in cannabinoid science, and the findings paint a nuanced picture that resists simple headlines.

Acute Effects: Higher Doses Raise Cortisol

A landmark study by Ranganathan et al. (2009) administered intravenous THC to healthy volunteers and found that THC significantly increased cortisol levels in a dose-dependent manner. Higher doses meant more cortisol. This aligns with what many people experience — especially at higher doses or when they are less experienced — as anxiety or a racing heart. The body appears to interpret the THC as a kind of stressor and activates the HPA axis accordingly.

This makes mechanistic sense. THC is a partial agonist at CB1 receptors, but unlike anandamide, it is not rapidly degraded by FAAH. It lingers. At higher concentrations, THC may actually compete with anandamide and 2-AG for CB1 receptor binding, potentially disrupting the endocannabinoid system’s native stress-buffering activity rather than enhancing it. As Hall et al. (2021) note in their review in the Journal of Clinical Medicine, “as far as the stress response is concerned, THC appears to act as a competitive inhibitor of AEA and 2-AG at CB1, and THC increases basal- and stress-induced glucocorticoids.”

Low Doses: A Different Story

The picture shifts at lower doses. Research by Cuttler et al. (2017), using ecological momentary assessment — tracking people in real-time in their daily lives — found that cannabis users reported significant reductions in perceived stress after using cannabis, with the effect being most pronounced at lower doses. While this study measured subjective stress rather than cortisol directly, it suggests a biphasic relationship: low doses may calm the stress response, while high doses may amplify it.

Animal research supports this pattern. Low doses of synthetic cannabinoids that activate CB1 receptors tend to produce anxiolytic effects, while higher doses produce anxiety-like behaviors — a pattern that parallels the cortisol findings [Rubino et al., 2008].

Chronic Use: Blunted Responses

Perhaps the most fascinating finding comes from studies on regular cannabis users. Cservenka et al. (2015) found that chronic cannabis users showed a blunted cortisol response to stress compared to non-users. Their HPA axis simply did not react as strongly to stressors. Somaini et al. (2012) similarly observed that long-term cannabis users had lower basal cortisol levels compared to controls.

This blunting likely reflects an adaptation: chronic CB1 receptor activation from regular THC exposure may lead to receptor downregulation, effectively recalibrating the set-point of the HPA axis. Whether this represents a benefit (less stress reactivity) or a concern (dampened ability to respond appropriately to genuine threats) likely depends on the individual and context.

Key insight: THC’s effect on cortisol appears to be biphasic and context-dependent — low doses may reduce stress signaling, while high doses or novel exposure may increase it. Chronic use appears to blunt the cortisol response overall, for better or worse.

CBD and Cortisol: Working With Your Body

Cannabidiol (CBD) tells a meaningfully different story. Unlike THC, CBD does not directly activate the CB1 receptor — the primary receptor through which THC exerts many of its effects on the HPA axis. Instead, CBD appears to modulate the stress response through several indirect but potentially complementary mechanisms.

How CBD May Lower Cortisol

• FAAH inhibition: CBD may inhibit FAAH, the enzyme that breaks down anandamide [Leweke et al., 2012]. By slowing anandamide degradation, CBD effectively boosts your body’s own endocannabinoid tone — reinforcing the “gatekeeper” that keeps the HPA axis from overactivating. This is arguably CBD’s most important mechanism for stress modulation.

• 5-HT1A receptor activation: CBD has been shown to activate the serotonin 5-HT1A receptor, which is involved in anxiety regulation [Russo et al., 2005]. Activation of this receptor is associated with reduced anxiety and may contribute to lower cortisol output.

• Neuroinflammatory modulation: A 2025 study by Akirav and colleagues found that chronic CBD treatment modulated neuroinflammatory pathways in stress models, including downregulation of TNF-alpha and NF-kB1 — inflammatory markers that can amplify HPA axis activity [Akirav et al., 2025]. Notably, these effects were sex-specific, with different mechanisms predominating in males versus females.

Clinical Evidence

An early but influential study by Zuardi et al. (1993) found that CBD administration was associated with a decrease in cortisol levels in human subjects, though the sample size was small. A 2021 systematic review by Hall et al. identified seven double-blind, placebo-controlled clinical trials of CBD for stress on a combined total of 232 participants, all of which showed that CBD was effective in significantly reducing the stress response.

However, not all evidence is uniformly positive. Mongeau-Perusse et al. (2022) found that long-term administration of 800 mg CBD daily was not more efficacious than placebo for modulating cortisol levels in individuals with cocaine use disorder, suggesting that context and population matter considerably.

A particularly intriguing 2024 study by Spinella et al. found that even the expectation of receiving CBD — without actually receiving it — was sufficient to blunt cortisol responses to acute stress, particularly in males (p<0.05 for the time-by-expectancy interaction). This suggests that some of CBD’s stress-relieving reputation may involve placebo or expectancy components, which does not negate its value but does add nuance.

A 2025 Finding: CBD and HPA Axis Hyperactivation

Research continues to complicate the picture. Jenkins et al. (2025), publishing in Psychopharmacology, found that in mice, CBD actually potentiated physiological and behavioral markers of HPA axis responsivity — meaning it made the stress response more reactive, not less, particularly in males. The authors note this has “implications for cannabinoid-based drug development targeting individuals” with stress disorders, and that sex differences in response were significant.

This does not necessarily contradict the human studies showing cortisol reduction, since animal models use different doses, routes, and species. But it does underscore that CBD’s relationship with cortisol is not a simple “CBD lowers stress” narrative. The dose, timing, sex of the individual, and chronicity of use all appear to matter.

The takeaway: CBD appears to work with your body’s existing stress-regulation machinery rather than overriding it, which may explain why many people find CBD calming without the anxiety that higher-dose THC can sometimes provoke. But the science is still evolving, and individual responses vary.

The Terpene Connection

Cannabinoids do not work in isolation. Terpenes — the aromatic compounds that give cannabis its diverse scent profiles — also appear to influence the stress response, and this is where the High Families framework becomes particularly useful for making informed choices.

• Linalool, found in lavender and many cannabis cultivars, has demonstrated anxiolytic and cortisol-reducing effects in aromatherapy research [Koulivand et al., 2013]. It is a signature terpene in the Uplifting High family.

• Myrcene, the most abundant terpene in cannabis, has shown sedative and muscle-relaxant properties in animal studies [do Vale et al., 2002]. Myrcene-dominant strains are central to the Relaxing High family, and their calming effects may partly reflect cortisol modulation.

• Beta-caryophyllene is unique among terpenes because it directly activates the CB2 receptor, which plays a role in inflammation and immune-mediated stress responses [Gertsch et al., 2008]. It is a key terpene in the Relieving High family and may help address the physical manifestations of chronic stress.

• Limonene has shown anti-stress effects in animal models, potentially through modulation of serotonin and dopamine pathways [Komiya et al., 2006]. It is another hallmark of the Uplifting High family.

This is a practical example of the entourage effect in action — cannabinoids and terpenes working together to shape your experience in ways that neither could achieve alone. Strains in the Entourage High family, with their complex multi-terpene profiles, may offer the most nuanced interaction with the stress response system. A 2025 study in Frontiers in Behavioral Neuroscience found that inflammatory state moderated the response to cannabis on negative affect and sleep quality in individuals with anxiety, further suggesting that the anti-inflammatory properties of both cannabinoids and terpenes may be central to their stress-modulating effects [Lisano et al., 2025].

The Stress-Cannabis Paradox: PTSD and CUD

One area where the cortisol-cannabis relationship becomes particularly complex is at the intersection of post-traumatic stress disorder (PTSD) and cannabis use disorder (CUD). As of 2025, 31 U.S. states list cannabis as a qualified treatment for PTSD. Yet longitudinal research shows that cannabis use is associated with higher PTSD symptom severity, including greater traumatic thought intrusions and depressive symptoms.

A 2025 study published on Research Square by a team investigating cannabinoid effects on stress generalization found that THC+CBD self-administration in rats actually promoted PTSD-like symptoms — specifically, the generalization of stress-coping responses to neutral stimuli that would not normally trigger a stress response. This effect was mediated by changes in astrocyte plasticity in the nucleus accumbens and was observed primarily in males.

This does not mean cannabis cannot help individuals with PTSD. It means the relationship is more complicated than “cannabis reduces stress.” For individuals with trauma histories, the cannabinoid modulation of cortisol and the HPA axis may have different — and sometimes counterproductive — effects compared to healthy individuals. Anyone considering cannabis for PTSD-related stress should work closely with a healthcare provider who understands both the potential benefits and risks.

Practical Implications

So what does all of this mean for your actual cannabis experience? Here is how to translate the science into smarter choices.

Dose Matters — A Lot

The biphasic nature of THC’s relationship with cortisol is arguably the most actionable finding. If you are using cannabis to manage stress, lower doses may be more effective than higher ones. Research consistently suggests that low-to-moderate THC doses tend to reduce anxiety and stress markers, while higher doses can increase them [Childs et al., 2017]. This is especially relevant for newer users whose endocannabinoid systems have not adapted to regular cannabinoid exposure.

Practical tip: Start with the lowest effective dose and increase gradually. If you notice your heart rate climbing or anxiety creeping in, you may have crossed the threshold where THC starts activating rather than calming the HPA axis.

Choose Your High Family Wisely

If stress relief is your goal, the terpene profile of your cannabis matters as much as the cannabinoid content. Consider:

• Relaxing High strains (myrcene-dominant) for evening wind-down and sleep support
• Uplifting High strains (limonene and linalool) for daytime mood elevation without sedation
• Relieving High strains (caryophyllene-rich) when stress manifests as physical tension
• Balancing High strains for gentle, beginner-friendly experiences that are less likely to spike cortisol

Consider CBD-Dominant or Balanced Options

Given CBD’s apparent ability to modulate cortisol through multiple mechanisms — without the biphasic risk of THC — CBD-dominant or balanced THC:CBD products may be particularly well-suited for stress management. Some users find that a 1:1 THC:CBD ratio offers the benefits of both cannabinoids while the CBD tempers THC’s potential to increase cortisol at higher doses.

Timing and Circadian Rhythm

Cortisol follows a circadian rhythm — highest in the morning and lowest around midnight. If you are using cannabis for stress relief, evening use aligns with your body’s natural cortisol decline. Morning use, particularly with higher-THC products, could theoretically interfere with the cortisol awakening response your body needs for healthy alertness. This is speculative, but the chronobiology is worth considering.

A Note on Chronic Use

The research on blunted cortisol responses in chronic users deserves thoughtful consideration. While a less reactive stress response might sound appealing, cortisol serves important functions — it helps you wake up, stay alert, and respond to genuine threats. If you are a daily user and notice you feel “flat” or have difficulty motivating in the morning, it may be worth exploring tolerance breaks to allow your HPA axis to recalibrate.

Sex Differences Matter

Multiple studies referenced in this article found significant sex differences in how cannabinoids affect cortisol and the HPA axis. The Jenkins et al. (2025) mouse study found CBD’s HPA-potentiating effects were more pronounced in males. The Spinella et al. (2024) human study found CBD expectancy effects on cortisol were largely driven by males. The Akirav et al. (2025) chronic stress study found different neuroinflammatory mechanisms in males versus females. While we do not yet have clear clinical guidelines based on these differences, they suggest that the “right” approach to cannabis for stress may differ by sex — an area where more research is needed.

Important: This article is for educational purposes only. Cannabis is not an approved treatment for any stress-related condition. If you are experiencing chronic stress, anxiety, or suspected cortisol-related health issues, please consult a healthcare professional. Cannabis may be part of a broader wellness approach, but it should not be the only tool in your kit.

Key Takeaways

• Your endocannabinoid system is your body’s native stress buffer. Anandamide gates the stress response; 2-AG helps shut it down. Chronic stress degrades this system.
• THC has a biphasic effect on cortisol: low doses may reduce stress hormone levels, while high doses — especially in less experienced users — may increase them.
• CBD may support cortisol regulation through indirect mechanisms including FAAH inhibition and serotonin receptor activation, though the evidence is still evolving and results vary by sex and context.
• Terpenes like linalool, myrcene, and beta-caryophyllene may independently contribute to stress modulation, making the full terpene profile of your cannabis as important as its THC/CBD content.
• Chronic cannabis use may blunt the cortisol response over time, which has both potential benefits and drawbacks worth monitoring.
• Choosing the right High Family and dosing low are the most practical steps for using cannabis as part of a stress management approach.

Frequently Asked Questions

Does cannabis lower or raise cortisol?

It depends on the dose, the individual, and the pattern of use. Research suggests that low doses of THC and most doses of CBD tend to lower cortisol, while high doses of THC — particularly in occasional users — may temporarily raise it [Ranganathan et al., 2009; Zuardi et al., 1993]. The relationship is biphasic, meaning the direction of the effect can reverse as the dose changes.

Can I use cannabis to treat chronic stress or adrenal fatigue?

While some people report that cannabis helps them manage stress, “adrenal fatigue” is not a recognized medical diagnosis, and cannabis is not an approved treatment for any stress-related condition. If you are dealing with chronic stress symptoms, a healthcare provider can help identify the root cause and appropriate interventions. Cannabis may complement a broader wellness approach, but it should not be relied upon as a sole treatment.

Is CBD better than THC for stress relief?

For cortisol management specifically, CBD may have a more consistently calming profile because it works through your body’s existing endocannabinoid system without the biphasic risk of THC. However, many people find that balanced THC:CBD products or specific terpene-rich strains offer the most effective subjective stress relief. The “best” option depends on your individual neurochemistry, tolerance, and what kind of stress you are managing.

Why do I sometimes feel more anxious after using cannabis?

This likely reflects THC’s dose-dependent activation of the HPA axis. At doses above your personal threshold, THC may trigger a cortisol surge that manifests as anxiety, racing heart, and hypervigilance. Your endocannabinoid system’s baseline state, your tolerance, and even your genetics (such as FAAH gene variants) all influence where that threshold sits. Lowering your dose or choosing strains with higher CBD content and calming terpenes like linalool or myrcene may help.

Does tolerance to cannabis change its effect on cortisol?

Yes. Studies show that chronic cannabis users have blunted cortisol responses compared to occasional users [Cservenka et al., 2015]. This likely reflects CB1 receptor downregulation from regular THC exposure. Tolerance breaks may allow the HPA axis and endocannabinoid system to recalibrate, potentially restoring a more responsive — and more therapeutic — interaction between cannabis and your stress hormones.

Sources

• Adam, E. K., et al. (2017). Diurnal cortisol slopes and mental and physical health outcomes. Psychoneuroendocrinology, 83, 25-41.
• Akirav, I., et al. (2025). Cannabidiol modulates neuroinflammatory and estrogen-related pathways in a sex-specific manner in a chronic stress model of depression. Cells, 14(2), 99.
• Blessing, E. M., et al. (2015). Cannabidiol as a potential treatment for anxiety disorders. Neurotherapeutics, 12(4), 825-836.
• Childs, E., et al. (2017). Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress. Drug and Alcohol Dependence, 177, 136-144.
• Chouker, A., et al. (2010). Motion sickness, stress and the endocannabinoid system. PLoS ONE, 5(5), e10752.
• Chrousos, G. P. (2009). Stress and disorders of the stress system. Nature Reviews Endocrinology, 5(7), 374-381.
• Cservenka, A., et al. (2015). Blunted cortisol stress reactivity in heavy cannabis users. Psychopharmacology, 232(3), 561-570.
• Cuttler, C., et al. (2017). Blunted stress reactivity in chronic cannabis users. Psychopharmacology, 234(14), 2299-2309.
• Evanson, N. K., et al. (2010). Fast feedback inhibition of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling. Endocrinology, 151, 4811-4819.
• Gertsch, J., et al. (2008). Beta-caryophyllene is a dietary cannabinoid. Proceedings of the National Academy of Sciences, 105(26), 9099-9104.
• Gray, J. M., et al. (2015). Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety. Journal of Neuroscience, 35(9), 3879-3892.
• Hall, S., et al. (2021). Enhancing endocannabinoid control of stress with cannabidiol. Journal of Clinical Medicine, 10(24), 5852.
• Herkenham, M., et al. (1991). Characterization and localization of cannabinoid receptors in rat brain. Journal of Neuroscience, 11(2), 563-583.
• Hill, M. N., et al. (2010). Endogenous cannabinoid signaling is essential for stress adaptation. Proceedings of the National Academy of Sciences, 107(20), 9406-9411.
• Jenkins, B. W., et al. (2025). Cannabidiol potentiates physiological and behavioral markers of HPA axis responsivity in female and male mice. Psychopharmacology, 243, 287-299.
• Koulivand, P. H., et al. (2013). Lavender and the nervous system. Evidence-Based Complementary and Alternative Medicine, 2013, 681304.
• Leweke, F. M., et al. (2012). Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Translational Psychiatry, 2(3), e94.
• Lisano, J. K., et al. (2025). Inflammatory state moderates response to cannabis on negative affect and sleep quality in individuals with anxiety. Frontiers in Behavioral Neuroscience, 19, 1549311.
• Morena, M., et al. (2016). Neurobiological interactions between stress and the endocannabinoid system. Neuropsychopharmacology, 41(1), 80-102.
• Petrowski, K., et al. (2025). Stress-buffer-hypothesis: blood endocannabinoids in healthy males under standardized psychosocial stress induction. Translational Psychiatry, 15, 517.
• Ranganathan, M., et al. (2009). The effects of cannabinoids on serum cortisol and prolactin in humans. Psychopharmacology, 203(4), 737-744.
• Russo, E. B., et al. (2005). Agonistic properties of cannabidiol at 5-HT1a receptors. Neurochemical Research, 30(8), 1037-1043.
• Somaini, L., et al. (2012). Psychobiological responses to unpleasant emotions in cannabis users. European Archives of Psychiatry and Clinical Neuroscience, 262(1), 47-57.
• Spinella, T. C., et al. (2024). The impact of cannabidiol expectancy on cortisol responsivity in the context of acute stress. Cannabis and Cannabinoid Research, 9(4), 1006-1014.
• Zuardi, A. W., et al. (1993). Effects of ipsapirone and cannabidiol on human experimental anxiety. Journal of Psychopharmacology, 7(1 Suppl), 82-88.